Nedaplatin Bronchial Artery Infusion Combined with Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer
ZHANG Li-wei
GUAN Xiu-hong
FENG Chong-yuan
Abstract：Objective:To evaluate the efficacy and safety of nedaplatin and docetaxel bronchial artery infusion(BAI) combined with docetaxel systemic chemotherapy in the treatments with advanced non-small cell lung cancer(NSCLC).Method:37 patients with advanced NSCLC by bronchial artery infusion of nedaplatin and docetaxel,and to give systemic chemotherapy,after finished more than two cycles to evaluate its effect and adverse reactions.Result:In 37 cases, 8 patients were CR,17 cases were PR,the effective rate was 67.6%,and the main adverse reaction was myelosuppression.Conclusion:Nedaplatin and docetaxel bronchial artery infusion combined with docetaxel systemic chemotherapy is a good curative effect,a lower adverse reaction,and can be tolerated by the patients with NSCLC.
Keywords：NedaplatinDocetaxelNon-small cell lung cancerBronchial artery infusion
Publication Date：2013-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 3-4 )